Literature DB >> 12949282

Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use.

Dario Prais1, Tommy Schonfeld, Jacob Amir.   

Abstract

OBJECTIVE: Preterm infants, especially those with chronic lung disease (CLD), are considered more susceptible to severe respiratory illness from respiratory syncytial virus (RSV) infection than healthy term infants, and are therefore targeted for prophylactic administration of immune globulins. The impact of this practice on the more severe cases of bronchiolitis (i.e., pediatric intensive care unit [PICU] admission, mechanical ventilation, mortality) has not been reported to date. The aim of this study was to evaluate PICU admissions, need for mechanical ventilation, and mortality attributable to RSV bronchiolitis in Israel before the introduction of RSV prophylaxis to the country. DESIGN AND
SETTING: Prospective survey of 11 PICUs in Israel during the RSV season (November 2000-March 2001). PATIENTS: All patients admitted to the PICU because of bronchiolitis, and the subgroups who needed mechanical ventilation or who died, were analyzed for known risk factors, namely, prematurity, CLD, and chronic oxygen dependence.
RESULTS: A total of 105 patients with RSV bronchiolitis met the inclusion criteria, of whom 33 were mechanically ventilated. Most of the patients (84% total admission, 88% ventilated) were born after 32 weeks' gestation, and 89% and 88%, respectively, did not have CLD. Only 16% and 9%, respectively, met any of the American Academy of Pediatrics criteria for RSV prophylaxis, such that 84% of the whole sample and 91% of the ventilated patients were not candidates for RSV prophylaxis. Five patients died, 2 of them with cyanotic heart disease.
CONCLUSIONS: Most of the infants with severe RSV bronchiolitis were born at term and did not have CLD. The great majority of patients admitted to the PICU for bronchiolitis were not candidates for RSV prophylaxis. Administration of RSV prophylaxis to the predefined high-risk population could be expected to yield no significant change in PICU admissions or number of infants needing mechanical ventilation. New risk-stratified guidelines for RSV prophylaxis are needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949282     DOI: 10.1542/peds.112.3.548

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain.

Authors:  G Cilla; A Sarasua; M Montes; N Arostegui; D Vicente; E Pérez-Yarza; E Pérez-Trallero
Journal:  Epidemiol Infect       Date:  2006-06       Impact factor: 2.451

2.  Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness.

Authors:  Cameron F Gunville; Marci K Sontag; Kristin A Stratton; Daksha J Ranade; Steven H Abman; Peter M Mourani
Journal:  J Pediatr       Date:  2010-03-24       Impact factor: 4.406

3.  A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.

Authors:  Bosco A Paes; Ian Mitchell; Anna Banerji; Krista L Lanctôt; Joanne M Langley
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

4.  Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis.

Authors:  Carla G García; Rafia Bhore; Alejandra Soriano-Fallas; Margaret Trost; Rebecca Chason; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatrics       Date:  2010-11-22       Impact factor: 7.124

Review 5.  Viral Bacterial Interactions in Children: Impact on Clinical Outcomes.

Authors:  Alejandro Diaz-Diaz; Cristina Garcia-Maurino; Alejandro Jordan-Villegas; Jeffrey Naples; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

6.  The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study.

Authors:  Michelle L Butt; Amanda Symington; Marianne Janes; Louann Elliott; Susan Steele; Bosco A Paes
Journal:  Eur J Pediatr       Date:  2010-12-22       Impact factor: 3.183

7.  Prophylaxis of respiratory syncytial virus in Canada in 2003.

Authors:  Joan L Robinson; Bonita E Lee
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

8.  Severe bronchiolitis in infants born very preterm and neurodevelopmental outcome at 2 years.

Authors:  Marion Gouin; Sylvie Nguyen; Christophe Savagner; Francoise Troussier; Géraldine Gascouin; Jean-Christophe Rozé; Cyril Flamant
Journal:  Eur J Pediatr       Date:  2013-01-22       Impact factor: 3.183

9.  Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database.

Authors:  Arne Simon; Roland A Ammann; Anja Wilkesmann; Anna M Eis-Hübinger; Oliver Schildgen; Edda Weimann; Hans U Peltner; Peter Seiffert; Angela Süss-Grafeo; Jessie R Groothuis; Johannes Liese; Ralf Pallacks; Andreas Müller
Journal:  Eur J Pediatr       Date:  2007-02-16       Impact factor: 3.183

10.  From bronchiolitis guideline to practice: A critical care perspective.

Authors:  James A Lin; Andranik Madikians
Journal:  World J Crit Care Med       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.